Bionano Genomics highlights OGM's utility in structural variant detection at AMP 2025.

Bionano Genomics showcased the utility of optical genome mapping (OGM) at the Association for Molecular Pathology Annual Meeting, highlighting its ability to detect structural variants (SVs) with greater clarity and sensitivity than traditional methods. Thirteen studies demonstrated OGM's potential in inherited disease testing, reproductive disorders, hematological malignancies, and solid tumors, enhancing its status as a high-resolution diagnostic tool.